Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have cancer that can be measured (for example, by scans or tests)
- You are physically able to carry out basic daily activities, at a level that meets one of the standard health scoring systems used in cancer care (your doctor will assess this)
- Your doctor believes you may be a good fit for one of the related treatment studies in the ComboMATCH program
- You have already had genetic or molecular testing done on your cancer through a laboratory approved by the National Cancer Institute
- Your cancer is advanced or has spread locally and needs treatment, AND either it has gotten worse after at least one standard treatment, or there is no standard treatment known to extend life for your type of cancer
- If you are 18 or older and your tumor can be safely biopsied, you are willing and able to have a small tissue sample taken for research if you join a treatment study
- If you are 18 or older and a biopsy is not safely possible, you have a stored tissue sample (taken within the last 12 months) available, and your cancer did not significantly shrink in response to any treatment given after that sample was collected
- If you are under 18, you have a stored tissue sample available that meets the required format (confirm with trial site)
Who may not be able to join:
- There are no specific exclusion criteria listed in this registration trial itself, however each individual treatment study within the ComboMATCH program has its own additional eligibility requirements that you would also need to meet (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Accrual of patients to ComboMATCH treatment trials; Assignment of patients to ComboMATCH treatment trials; Enrollment rates to ComboMATCH treatment trials
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.